Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
Sara Hall, Christina D. Orrú, Geidy E. Serrano, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 538
Clinical effects of Lewy body pathology in cognitively impaired individuals
Corinne Quadalti, Sebastian Palmqvist, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1964-1970
Open Access | Times Cited: 81
Cognitive effects of Lewy body pathology in clinically unimpaired individuals
Sebastian Palmqvist, Marcello Rossi, Sara Hall, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1971-1978
Open Access | Times Cited: 80
α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
Anna Grossauer, Greta Hemicker, Florian Krismer, et al.
Movement Disorders Clinical Practice (2023) Vol. 10, Iss. 5, pp. 737-747
Open Access | Times Cited: 57
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
Giuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 37
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
Kathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
Annika Kluge, Eva Schaeffer, Josina Bunk, et al.
Movement Disorders (2024) Vol. 39, Iss. 8, pp. 1289-1299
Open Access | Times Cited: 25
Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
Kyu-Hwan Shim, Min Ju Kang, Young Chul Youn, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 61
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease
Lorenzo Barba, Samir Abu‐Rumeileh, Steffen Halbgebauer, et al.
Neurology (2023) Vol. 101, Iss. 1
Open Access | Times Cited: 24
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers
Lucy L. Gibson, Carla Abdelnour, Joyce R. Chong, et al.
Current Opinion in Neurology (2023)
Open Access | Times Cited: 23
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification
Angela Mammana, Simone Baiardi, Marcello Rossi, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 10, pp. 2001-2010
Open Access | Times Cited: 15
α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden
Johannes Levin, Simone Baiardi, Corinne Quadalti, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4351-4365
Open Access | Times Cited: 14
Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort
Niyatee Samudra, D. Luke Fischer, Steven Lenio, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3334-3341
Open Access | Times Cited: 13
Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson’s Disease Diagnosis and Duration
Eva Schaeffer, Annika Kluge, Claudia Schulte, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 4, pp. 667-679
Open Access | Times Cited: 13
α-Synuclein seed amplification technology for Parkinson’s disease and related synucleinopathies
Claudio Soto
Trends in biotechnology (2024) Vol. 42, Iss. 7, pp. 829-841
Closed Access | Times Cited: 10
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 10
CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders
Chloe Anastassiadis, Iván Martínez-Valbuena, Anna Vasilevskaya, et al.
Neurology (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 10
A skin-specific α-Synuclein seeding amplification assay for diagnosing Parkinson’s disease
Yaoyun Kuang, Hengxu Mao, Tingting Gan, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for specialty care
Bradford C. Dickerson, Alireza Atri, Carolyn Clevenger, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 9
Elevated Cerebrospinal Fluid α‐Synuclein Seeding Activity Predicts Central Lewy Body Diseases
David S. Goldstein, Parvez Alam, Patti Sullivan, et al.
Movement Disorders Clinical Practice (2025)
Closed Access | Times Cited: 1
Lewy body diseases and the gut
Timothy R. Sampson, Malú G. Tansey, Andrew B. West, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Fluid and Biopsy Based Biomarkers in Parkinson's Disease
David G. Coughlin, David J. Irwin
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 932-954
Open Access | Times Cited: 21
Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis
Yuanchu Zheng, Siming Li, Yang Chen, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3949-3967
Closed Access | Times Cited: 20
Amidst an amygdala renaissance in Alzheimer’s disease
Kaitlin Stouffer, Xenia Grande, Emrah Düzel, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 816-829
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top